Indication
Rhabdomyosarcoma
Rhabdomyosarcoma is an aggressive malignant soft tissue sarcoma arising from primitive mesenchymal cells committed to skeletal muscle differentiation. Read more about Rhabdomyosarcoma
14 drugs 13 manufacturers
Drugs that treat it
Common Rhabdomyosarcoma therapies.
DACTINOMYCIN
DACTINOMYCIN
DACTINOMYCIN
DACTINOMYCIN
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonRhabdomyosarcoma is an aggressive malignant soft tissue sarcoma arising from primitive mesenchymal cells committed to skeletal muscle differentiation.
It represents the most common soft tissue sarcoma of childhood and adolescence, though it can occasionally develop in adults.
Tumors most frequently arise in the head and neck, genitourinary tract, extremities, and trunk.
Pathophysiologically, the disease is characterized by immature myogenic precursors called rhabdomyoblasts and is classified into distinct histologic and molecular subtypes, predominantly embryonal and alveolar forms, the latter often driven by characteristic PAX3- or PAX7-FOXO1 gene fusions.
Clinically, it typically presents as an enlarging, painless mass or produces site-dependent signs of local tissue invasion and organ dysfunction.
- nih.gov
Rhabdomyosarcoma is an aggressive malignant soft tissue sarcoma arising from primitive mesenchymal cells committed to skeletal muscle differentiation It represents the most common soft tissue sarcoma of childhood and adolescence, though it can occasionally develop in adults Pathophysiologically, the disease is characterized by immature myogenic precursors called rhabdomyoblasts and is classified into distinct histologic and molecular subtypes, predominantly embryonal and alveolar forms, the latt...
- nih.gov
Rhabdomyosarcoma is an aggressive malignant soft tissue sarcoma arising from primitive mesenchymal cells committed to skeletal muscle differentiation It represents the most common soft tissue sarcoma of childhood and adolescence, though it can occasionally develop in adults
- cancer.org
Tumors most frequently arise in the head and neck, genitourinary tract, extremities, and trunk
- cancer.gov
Pathophysiologically, the disease is characterized by immature myogenic precursors called rhabdomyoblasts and is classified into distinct histologic and molecular subtypes, predominantly embryonal and alveolar forms, the latter often driven by characteristic PAX3- or PAX7-FOXO1 gene fusions
- cancer.gov
Clinically, it typically presents as an enlarging, painless mass or produces site-dependent signs of local tissue invasion and organ dysfunction
Personalize your experience
Follow Rhabdomyosarcoma and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.